Article
Engineering NKG2D ligand affinity transforms EGFR-targeted NK cell engagers into high-potency effectors against pancreatic cancer
2026-01-20
Abstract excerpt
<title>Abstract</title> <p> <bold>Background</bold> Pancreatic ductal adenocarcinoma (PDAC) often escapes T cell–mediated immunity through impaired major histocompatibility complex class I (MHC-I) antigen presentation, rendering it largely refractory to current immunotherapies. Because natural killer (NK) cells are capable of eliminating MHC-I–low tumor cells, redirecting NK cytotoxicity represents a promising...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0b9c134a-172b-51c6-a391-72e1788ca23b
- DOI
- 10.21203/rs.3.rs-8589580/v1
